Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
Lab-grown human skin equivalent for cosmetic and pharmaceutical testing
Labskin is a contract research organisation offering preclinical testing services built around a proprietary full-thickness, lab-grown human skin equivalent. The model…
AI-powered molecular design software for medicinal chemists
deepmirror is a software company developing an AI-powered drug design application for medicinal chemists. Its no-code interface integrates generative molecular design with…
Microbiome emulation platform for drug development de-risking
BioCorteX is a biotech company that applies computational emulation to model interactions between drugs, the human microbiome, and the immune system. Its platform uses physics-…
Fragment-based drug discovery platform for oncology and CNS disorders
Astex Pharmaceuticals is a drug discovery and development company pioneering fragment-based drug discovery through its proprietary Pyramid platform, applied to oncology and…
Small molecule CDMO delivering process chemistry and API manufacturing services
Onyx Scientific is a contract manufacturing organisation specialising in small molecule active pharmaceutical ingredients. The company supports pharma and biotech clients from…
CRISPR-engineered tumour-infiltrating lymphocyte therapy
Intima Bioscience is a clinical-stage biotechnology company developing CRISPR gene-edited tumour-infiltrating lymphocyte therapies for solid tumours. Its platform targets CISH, an…
Bispecific antibody-drug conjugates for cancer-selective precision therapy
BiVictriX Therapeutics is a clinical-stage biotechnology company developing bispecific antibody-drug conjugates for cancer. The platform targets pairs of cancer-specific antigens…
AAV gene therapy company targeting inherited and common retinal diseases
Beacon Therapeutics is a clinical-stage UK biopharma company developing adeno-associated virus (AAV) gene therapies for retinal diseases causing blindness. Its lead programme,…
AI-driven tRNA synthetase platform for novel small molecule therapeutics
Oxford Drug Design is an Oxford biotech developing small molecule therapeutics using an integrated platform combining aminoacyl-tRNA synthetase biology with proprietary generative…
Pharma-university venture funding early-stage translational research
Apollo Therapeutics is a biopharma company advancing therapeutic programmes derived from research at partner universities including Cambridge, Imperial College London, UCL, King's…
Broad-spectrum intranasal antivirals targeting respiratory viral infections
Pneumagen is a Scottish clinical-stage biotechnology company developing broad-spectrum intranasal antiviral therapies. Pneumagen’s platform generates multivalent carbohydrate…
Multispecific immune cell engagers targeting gamma delta T cells
Cytospire Therapeutics is developing multispecific engager antibodies designed to enhance and direct the activity of gamma delta T cells for the treatment of cancer and autoimmune…